Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
Intervalo de año de publicación
1.
J Oleo Sci ; 70(5): 731-736, 2021 May 01.
Artículo en Inglés | MEDLINE | ID: mdl-33840667

RESUMEN

The n-3 type polyunsaturated fatty acids (n-3PUFAs), including eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), from fish oil exhibit health benefits such as triacylglycerol- and cholesterol-lowering effects. Some pelagic fishes contain long-chain monounsaturated fatty acids (LC-MUFAs) such as eicosenoic acid (C20:1), which exert health-promoting effects. However, no study has evaluated beneficial effects of n-3PUFA and LC-MUFA combination. Here, we investigated effects of simultaneous treatment with n-3PUFA (EPA and DHA) and LC-MUFA (cis-5-C20:1 and cis-7-C20:1) and found that n-3PUFA and LC-MUFA combination significantly decreased lipid accumulation and reduced total cholesterol in HepG2 cells. Cholesterol level was significantly lower in DHA + cis-7-C20:1 group than in DHA + EPA group. These results suggest the importance of LC-MUFA as a functional molecule in fish oil.


Asunto(s)
Colesterol/metabolismo , Ácidos Grasos Monoinsaturados/farmacología , Ácidos Grasos Omega-3/farmacología , Metabolismo de los Lípidos/efectos de los fármacos , Ácidos Docosahexaenoicos/aislamiento & purificación , Ácidos Docosahexaenoicos/farmacología , Combinación de Medicamentos , Sinergismo Farmacológico , Ácido Eicosapentaenoico/aislamiento & purificación , Ácido Eicosapentaenoico/farmacología , Ácidos Grasos Monoinsaturados/aislamiento & purificación , Ácidos Grasos Omega-3/aislamiento & purificación , Aceites de Pescado/química , Células Hep G2 , Humanos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA